Ranolaze®
-
Generic name: Ranolazine
-
Pharmacologic Category: Anti-anginal
-
Dosage Forms: 500 mg extended-release tablet
-
Mechanism of Action: A direct, selective inhibitor of Factor Xa

- Treatment of chronic/refractory angina with no effect on heart rate and blood pressure.
Description:
Ranolazine acts by inhibiting the cardiac late sodium current (INa) and
hence prevents sodium dependent calcium accumulation in the cell.
It is important to know, 25-30% of patients with coronary artery disease have
persistent angina pectoris despite of PCI with or without optimal medical therapy